NFKB1 and diabetes mellitus: Furthermore, NF-kB (P < 0.01), TNF-α, and IL-6 (P < 0.05)were significantly reduced, indicating that PAItrap3 may alleviate metabolic dysfunction in diabetes by suppressing inflammatory pathways (Table 2).